Luke Howard

Also affiliated with Hammersmith Hospital

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 11 papers. Top paper: “Comparison of Contemporary Risk Scores in All Groups of Pulmonary Hypertension”.

Comparison of Contemporary Risk Scores in All Groups of Pulmonary Hypertension

CHEST Journal(2024)10.1016/j.chest.2024.03.018

N/A

0.901DataRank · unranked

38 citations

Henning Gall, Meike Fünderich, Martin R. Wilkins, Luke Howard, David G. Kiely +49 more

Blood DNA methylation profiling identifies cathepsin Z dysregulation in pulmonary arterial hypertension

Nature Communications(2024)10.1038/s41467-023-44683-0

N/A

0.600DataRank · unranked

21 citations

Yukyee Wu, Harmen H. M. Draisma, John Wharton, Emilia M. Swietlik, Inês Cebola +21 more

Incremental value of cardiopulmonary exercise testing in intermediate-risk pulmonary arterial hypertension

The Journal of Heart and Lung Transplantation(2022)10.1016/j.healun.2022.02.021

N/A

0DataRank · unranked

29 citations

Franz Rischard, Francesco Lo Giudice, Luke Howard, Silvia Papa, Gabriele Valli +11 more

Defining the clinical validity of genes reported to cause pulmonary arterial hypertension

Genetics in Medicine(2023)10.1016/j.gim.2023.100925

N/A

0DataRank · unranked

75 citations

Micheala A. Aldred, Srimmitha Balachandar, Dennis Dooijes, Christina A. Eichstaedt, Stefan Gräf +71 more

Inflammation and Obesity Correlate in Pulmonary Hypertension but Are Associated with Diverging Outcomes

American Journal of Respiratory and Critical Care Medicine(2025)10.1164/rccm.202412-2393oc

N/A

0DataRank · unranked

2 citations

Priscilla Correa‐Jaque, R. Jones, Harm Jan Bogaard, J. Chan, Colin Church +89 more

Male survival disadvantage in pulmonary hypertension: independent of aetiology, age, disease severity, comorbidities and treatment

EBioMedicine(2025)10.1016/j.ebiom.2025.106063

N/A

0DataRank · unranked

2 citations

Jeffrey Annis, Meike Fünderich, Jochen Wilhelm, David G. Kiely, Luke Howard +71 more

Survival Outcomes and Impact of Targeted PAH Therapy in Portopulmonary Hypertension in the PVRI GoDeep Meta‐Registry

Pulmonary Circulation(2025)10.1002/pul2.70121

N/A

0DataRank · unranked

3 citations

Athiththan Yogeswaran, Meike Fünderich, David G. Kiely, Andrew J. Sweatt, Roham T. Zamanian +29 more

GDF15 is a putative biomarker for distinguishing pulmonary veno-occlusive disease and pulmonary arterial hypertension

Journal of Clinical Investigation(2025)10.1172/jci199159

N/A

0DataRank · unranked

1 citations

Eckart M. D. D. De Bie, Jacqueline T. DesJardin, Prajakta Ghatpande, Stefan Ting Graf, Luke Howard +17 more

Whole-Blood RNA Profiles Associated with Pulmonary Arterial Hypertension and Clinical Outcome

American Journal of Respiratory and Critical Care Medicine(2020)10.1164/rccm.202003-0510oc

N/A

0DataRank · unranked

74 citations

P. Morales Otero, John Wharton, Emilia M. Swietlik, Sokratis Kariotis, Lars Harbaum +26 more

Inflammation and Obesity Correlate in Pulmonary Hypertension but Associate with Diverging Outcomes.

Apollo (University of Cambridge)(2025)10.17863/cam.122938

N/A

0DataRank · unranked

0 citations

Correa-Jaque, Priscilla, Jones, Rowena, Bogaard, Harm J, Chan, Justine, Church, Colin +25 more

Rare variant analysis of 4241 pulmonary arterial hypertension cases from an international consortium implicates FBLN2, PDGFD, and rare de novo variants in PAH

Genome Medicine(2021)10.1186/s13073-021-00891-1

N/A

0DataRank · unranked

86 citations

Emilia M. Swietlik, Carrie L. Welch, Michael W. Pauciulo, Jacob Hagen, Xueya Zhou +89 more